demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
DPP-4 inhibitor Abuhasira

7 studies excluded by filtering options 0

7084 Fadini, 2020 2200excludednot a RCTrisk of bias not avaialble
7085 Rhee (National Health Insurance Review and Assessment Service of Korea), 2021 1120not a RCTrisk of bias not avaialble
7087 Noh, 2021 0150selection pending
7088 CORONADO, 2020 1130not a RCTrisk of bias not avaialble
7090 Strollo, 2021 2990excludednot a RCTrisk of bias not avaialble
7322 Rhee (National Health Insurance Service database), 2021 1120not a RCTrisk of bias not avaialble
9252 Guardado-Mendoza, 2022 013selection pending